Comments on: VC funding up, biotech outpaces other industries

By: Geoff Hirshfield

Geoff Hirshfield — Mon, 08 Sep 2008 20:36:24 +0000

Do you have a list of companies that received vc funding for the year 2008? Please let me know. I hope to hear from you soon.

By: IPO roundup: Is the window slamming on life sciences? » VentureBeat

IPO roundup: Is the window slamming on life sciences? » VentureBeat — Thu, 14 Feb 2008 13:20:49 +0000

[...] gate over the past year or so haven’t performed very well. That stands in sharp contrast to buoyant venture-capital financings in the sector, which are apparently being sustained by the belief that big pharma and [...]

By: Mike

Mike — Tue, 22 Jan 2008 17:44:27 +0000

Does anyone know if any organization collects this type of data for Europe or Asia?

While I agree that valuations might be a bit high right now, I think that this seems to be a good time to be dumping VC money into biotech companies. Unless its a very late stage investment, most of these biotech companies are looking to be acquired/do an IPO many years down the line. Big pharma is still flush with cash and the IPO market will bounce back in a couple of years.

By: Steven

Steven — Mon, 21 Jan 2008 21:38:33 +0000

Great post. The question is whether or not the moeny put in ‘07 can warrant the valuations being given. Back in 2001, we experienced the same concerns and ended up in a recession. Yes, investors are much smarter the second time around (we hope) but if the economy is indeed headed (or in) a recession, the exit strategy for many of the investments made (IPO) may not happen in 2008 and will most likely wait till 2009. I expect end of 2008, should be a very active quarter.

By: Tom Kosnik

Tom Kosnik — Sun, 20 Jan 2008 15:56:03 +0000

Dear David,
Thanks for your thoughtful commentary in several articles on the PWC Moneytree statistics on VC Investing. My colleague, Professor Lena Ramfelt and I have been following the Venture Capital industry together since 1997. It is great to get your analysis, and your thoughtful sharing of the source documents from PWC Moneytree.

Lena and I are particularly interested in VC investing in the target Market Categories where we do case studies for Global Entrepreneurship Education: Clean-Tech Overall; Clean and Green Health Care and Wellness Products; Clean Water; Enterprise Software; Interactive Entertainment; Social Networking; Web 2.0 overall; and Wireless Value Added Services. If you are interested, I will gladly pass on things we uncover in those areas if you’ll do likewise.

Thanks.
Keep on Writing!!!
Tomk and Lenar

By: Don Jones

Don Jones — Sat, 19 Jan 2008 15:32:05 +0000

What’s amazing is that the investments continue, even though the exit environment – whether M&A or IPO – is so bad for VCs. Their company development assumptions have not only gone back to the normal 4-6 years, but unless the IPO market comes back, even that assumption looks too short. Hard to see how the venture capital guys are making any money other than their 2%.

By: VentureBeat » VC funding up, cleantech and life sciences strong

VentureBeat » VC funding up, cleantech and life sciences strong — Sat, 19 Jan 2008 05:04:07 +0000

[...] largesse, while medical devices and cleantech showed strong growth. We slice and dice the numbers over at VentureBeat Life Sciences. Tagged venture capital VentureBeat [...]